IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fate Therapeutics
University of Chicago
Memorial Sloan Kettering Cancer Center
University of Southern California
Nurix Therapeutics, Inc.
DEKA Biosciences
AstraZeneca
Shanghai Jiao Tong University School of Medicine
University of Chicago
Novartis
AIDS Malignancy Consortium
Oncology Institute of Southern Switzerland
Memorial Sloan Kettering Cancer Center
Genentech, Inc.
Massachusetts General Hospital
University of Kentucky
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center